ArticleNaunyn-Schmiedeberg's archives of pharmacology2025

RBM15-mediated m6A modification of XPR1 promotes the malignant progression of lung adenocarcinoma.

Changpeng Sun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.